HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment
Clinical trial NCT04613297 · COMPLETED
Trial details
- NCT number
- NCT04613297
- Sponsor
- Hopital Foch
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2022-07-19
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.